AngioDynamics to Present at the 44th Annual J.P. Morgan Healthcare Conference
News > Health News
Audio By Carbonatix
5:00 AM on Monday, December 22, 2025
The Associated Press
LATHAM, N.Y.--(BUSINESS WIRE)--Dec 22, 2025--
AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced, that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the 44 th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 14, 2026. The Company's presentation will begin at 3:00 p.m. (PT).
A live webcast of the event will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following the event.
About AngioDynamics, Inc.
AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients.
The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20251222942416/en/
CONTACT: Investors:
Stephen Trowbridge
Executive Vice President & CFO
518-795-1408
Media:
Saleem Cheeks
Vice President, Communications
518-795-1174
KEYWORD: CALIFORNIA NEW YORK UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: ONCOLOGY MEDICAL DEVICES HEALTH CLINICAL TRIALS CARDIOLOGY BIOTECHNOLOGY
SOURCE: AngioDynamics, Inc.
Copyright Business Wire 2025.
PUB: 12/22/2025 08:00 AM/DISC: 12/22/2025 08:00 AM
http://www.businesswire.com/news/home/20251222942416/en
